Our Strategy and Executive Partners have acquired a wealth of knowledge through their extensive pharma experience. We are available to offer insight on a variety of critical issues facing the drug market today. Contact us to schedule an interview with a member of our leadership team or to request a comment on an industry issue.
Leadership Team & Expertise
Subbarao Jayanthi: Corporate Strategy, Life Cycle Management, Mergers and Acquisitions, Biosimilars, Co-Promotion Effectiveness
Rich Tinsley: Gene Therapies, Strategy, Commercialization, Life Cycle Management, Forecast Modeling
Jim Hoyes: Corporate Development, Global Operations, Commercialization, Licensing, Mergers and Acquisitions, Co-Promotion Effectiveness
Frank Koos: Pharmaceutical Marketing, Business Development, Sales Force Leadership, High Value B2B, Strategic Account Management, Team Structure
Nick DeSanctis: New Product Planning, Portfolio Management, Life Cycle Management, Target Value Profile, Therapeutic Area Strategy
Jose De Leon: New Product Planning, Early Commercialization, Global Product Launch, Global Product Marketing, Life Cycle Management, Global Strategic Planning
Therapeutic Focus Areas
What is the outlook for a second or third entry into the biosimilars market?
How will recent approval of the first gene therapy in the United States impact future gene therapies?
What pricing hurdles do gene therapy treatments need to overcome?